Abstract:Catalytic dehalogenative deuteration and tritiation with D2/T2 gas is a widely employed method for precisely introducing hydrogen isotopes into specific positions within organic molecules. While palladium(0) based heterogeneous catalysts, such as Pd/C, are commonly used for this purpose, challenges related to functional group tolerance and incomplete iso-tope incorporation are often encountered, particularly with respect to aryl bromides and chlorides. These long-standing issues pose a hurdle to achieving optimal results in tracer synthesis. The limited incorporation of isotopes for aryl bro-mides and chlorides presents a significant obstacle to the application of this method in the preparation of high specific activity tritium tracers. Herein, we present a novel palladium catalytic system using Zn(OAc)2 as an additive, which ena-bles homogeneous dehalogenative deuteration and tritiation using D2/T2 gas. Under mild reaction conditions, a wide range of drug-like aryl halides and pseudohalides undergo selective deuteration with complete isotope incorporation. The reaction displays excellent compatibility with diverse functional groups, including multiple bonds, O/N-benzyl, and cy-ano groups, which are frequently problematic in Pd/C reactions. Furthermore, this method was successfully applied to the tritiation of four halogenated pharmaceutically relevant molecules, resulting in predictable high specific activity per halogen atom (26.5-27.7 Ci/mmol). Notably, the developed system allows gram-scale preparation of a deuterium-containing intermediate, a crucial step in synthesizing a deuterium-labeled drug molecule. A reaction pathway involving a key intermediate, Pd(Ar)OAc, was proposed to activate hydrogen gas during dehalogenative deuteration and tritiation. This innovative method has potential to change the practice of dehalogenative deuteration and tritiation in the realm of hydrogen isotope labeling.

Direct Multi‐Deuterium Labelling of Pirtobrutinib

Versatile Regioselective Deuteration of Indoles Via Transition-Metal-Catalyzed H/D Exchange

Homogenous Palladium-Catalyzed Dehalogenative Deuteration and Tritiation of Aryl Halides with D2/T2 Gas

Cesium Amide‐Catalyzed Selective Deuteration of Benzylic C‐H Bonds with D2 and Application for Tritiation of Pharmaceuticals

Synthesis of Multideuterated (Hetero)aryl Bromides by Ag(I)-Catalyzed H/D Exchange

Deuteration and Tritiation of Pharmaceuticals by Non-Directed Pd Catalyzed C–H Activation in Heavy and Super-Heavy Water

Alkali Metal Amide–Catalyzed Deuteration and Tritiation of Pharmaceuticals

Late-Stage C–H Deuteration of Organic Compounds via Ligand-Enabled Palladium-Catalyzed Hydrogen Isotope Exchange

Palladium(II)-Mediated C-H Tritiation of Complex Pharmaceuticals

LC-MS/MS characterization of pirtobrutinib impurities and product degradation: stability studies

Directed Aromatic Deuteration and Tritiation of Pharmaceuticals by Heavy Alkali Metal Amide Catalysts

Frustrated Lewis pairs: A real alternative to deuteride/tritide reductions

Deuterated reagents in multicomponent reactions to afford deuterium-labeled products

Selective Deuteration and Tritiation of Pharmaceutically Relevant Sulfoximines

Synthesis of deuterium labeled dabigatran etexilate

Tritiation of aryl thianthrenium salts with a molecular palladium catalyst

Iridium‐Catalysed C(sp3)−H Activation and Hydrogen Isotope Exchange via Nitrogen‐Based Carbonyl Directing Groups

Hydrogen Isotope Labeling of Pharmaceuticals via Dual Hydrogen Isotope Exchange Pathways

Catalyst-free decarboxylative deuteration using tailored photoredox-active carboxylic acids

Highly selective single and multiple deuteration of unactivated C(sp3)-H bonds

Deuterated Liquid Crystals - design and synthesis of deuterium labelled 4,4ʺ-dialkyl-2′,3′-difluoro-[1,1′:4′,1ʺ]terphenyls using batch and continuous flow systems